brodalumab: Clinical Trials

7 trials of brodalumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 withdrawn. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Recruiting 1, Withdrawn 1
Phase 21Completed 1

Follow brodalumab: new trials by email Literature Review of brodalumab trials Research Report on brodalumab

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brodalumab in the Treatment of Immune-Related Adverse Events
Brodalumab, CT scan - Breast Cancer, Esophageal Cancer
Phase 1RecruitingBrian Henick, MD112025-03-112026-05-13
A Study of KHK4827 in Patients With Systemic Sclerosis
KHK4827 - Systemic Sclerosis
Phase 1CompletedKyowa Kirin Co., Ltd.82017-10-062025-07-11
A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab
Brodalumab - Psoriasis
Phase 1CompletedBausch Health Americas, Inc.1452014-09-012017-06-20
Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects
Brodalumab - Psoriasis
Phase 1CompletedBausch Health Americas, Inc.312013-09-012017-04-10
A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis
Placebo, KHK4827 - Psoriasis
Phase 1CompletedKyowa Kirin Co., Ltd.482011-11-012012-11-02
Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma
AMG 827 or Placebo - Asthma
Phase 1WithdrawnAmgen2011-06-012013-11-25
Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis
Brodalumab, Placebo - Rheumatoid Arthritis
Phase 1 / Phase 2CompletedAmgen402008-10-272021-11-26

Conditions studied

Psoriasis (3)  ·  Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Kidney Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Amgen (2)  ·  Bausch Health Americas, Inc. (2)  ·  Kyowa Kirin Co., Ltd. (2)  ·  Brian Henick, MD (1)

Countries

United States (3)  ·  Japan (2)  ·  Australia (1)  ·  New Zealand (1)

Top investigators

Brian Henick, MD (1)

Results publications

PMID 24286136, PMID 36997069